INFOGEST 2.0 Protocol Applied to Animal-Derived Milk and Dairy Products: A Systematic Review of Six Years of Scientific Effort Authors: Giuseppe De Santis, Olubukunmi Amos Ilori, Diana Marisol Abrego-Guandique, Pierluigi Plastina, Paola Tucci, Erika Cione Published: 2026 ABSTRACT The INFOGEST protocol is a standardised in vitro digestion model widely utilised to evaluate the digestibility and bioaccessibility of nutrients in diverse food matrices. This review focuses on its application since 2020 (after the publication of the INFOGEST 2.0 model) to milk and dairy products, which often serve as a suitable food matrix in digestion studies. By analysing 50 studies selected using a semi-automated method, this review highlights its strong performance in reproducing general digestive trends, including peptide fingerprint profiling, consistent high-protein digestibility, and matrix-dependent lipid and mineral bioaccessibility. The model is particularly effective in evaluating structural modifications of dairy products and their impact on digestive behaviour. However, its application remains skewed toward bovine systems, limiting broader relevance to other dairy matrices. Methodological variability, including protocol modifications and emerging semi-dynamic adaptations, poses challenges to reproducibility. Furthermore, reliance on simplified downstream models constrains the physiological interpretation of bioactivity and nutrient absorption. Future progress requires harmonised dynamic extensions, expanded use of advanced biological systems, and inclusion of diverse dairy matrices. Collectively, these advances will support a shift from descriptive bioaccessibility toward more predictive assessments of nutrient bioavailability. This six-year, non-topic-dependent bibliometric analysis contextualises the expanding adoption of INFOGEST 2.0 as reflected in its versatility and evolving scope, positioning it as a cornerstone tool for advancing our understanding of dairy nutrition, digestion-derived bioactivity, and ultimately, the relationship between dairy consumption and human health. 1. Introduction In recent decades, scientific research in the field of food and nutrition has made considerable progress, taking full advantage of the development of new methodologies for the study of in vitro digestion. The concept of in vitro gastrointestinal digestion, also called digestomics, is a technique used to simulate and study the process of digestion of food outside the human body under controlled conditions [1]. This method reproduces the biochemical, enzymatic and physical conditions of the human gastrointestinal tract, allowing for the observation and analysis of food and nutrient degradation and transformation during digestion [2,3]. There are two types of in vitro digestion that are commonly used: static and dynamic methods. Static models are much less complex and easier to set up. Hence, the static digestomic protocol was proposed in 2014 by the COST Action called INFOGEST for the static model. This involved a network of multidisciplinary experts from over 30 countries developing a static digestion method, modelled after a healthy adult digestion apparatus, with international consensus to harmonise experimental conditions. Following widespread adoption, increased enzyme availability, and a need to better understand the degradation of certain food components, the model was further standardised (as INFOGEST 2.0) in 2019 to include, amongst others, the oral phase and gastric lipase [2,3]. The INFOGEST 2.0 model is a static digestion technique that maintains a constant pH at each stage of the digestion and a constant ratio between the meal and the digestive fluid. The digestion process is divided into three phases: oral, gastric, and intestinal (Figure 1). This allows for the evaluation of food digestion endpoints while avoiding the use of laboratory animals. It also permits the examination of the products of food macromolecules as a result of digestion (fatty acids, simple sugars, peptides/amino acids, etc.) [3], the study of micronutrient bioaccessibility [4,5], and the determination of the digestive stability of different food bioactive components, such as microRNAs [6] and genetically modified plant products [7]. Milk is an important dietary source of essential vitamins and minerals, high-quality proteins, and fats, and it is a sustainable and complete food [8,9]. The relationship between milk fat and health has been widely investigated [10,11]. Although healthy people suffer from milk-related gastrointestinal discomfort despite not being lactose intolerant, the mechanisms behind such conditions are still unknown [12]. The interaction of milk during digestion is thus of great importance in providing tools towards a better understanding of the effects of milk on health [13]. While previous reviews have broadly addressed the INFOGEST protocol for the digestion of numerous food groups, the dairy group has not been critically examined [1,14], and none have systematically focused exclusively on the updated INFOGEST framework applied to the full range of milk and dairy products. Moreover, earlier works did not integrate a systematic review of studies covering both macro- and micronutrient bioaccessibility. Considering that milk is usually employed as a validation matrix for this protocol and given the potential variations in protocol adaptations that usually follow the harmonisation of a model [15,16], we aimed to give a coherent understanding of the extended dairy digestion within the INFOGEST framework following the publication of the INFOGEST 2.0 model recommendation. 2. Materials and Methods 2.1. Systematic Literature Review The systematic review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines [17]. The methodological approach is based on three steps: paper location and selection, paper analysis, and results presentation. We adopted a semi-automated approach using the MySLR platform upon registration (available at https://myslr.unical.it, accessed on 6 January 2026). This digital tool reproduces “human-like intelligence” as closely as possible by implementing the LDA algorithm. We loaded the papers on MySLR to offer a complete and exhaustive overview of scientific research [18]. The MySLR platform was already used previously [19,20]. The MySLR platform also performed an initial automated deduplication and exclusion of non-original articles (reviews, editorials, conference papers, letters) using a pre-trained classifier based on publication type metadata. 2.2. Paper Location, Selection, and Data Extraction Two investigators (G.D.S. and D.M.A-G.) independently conducted systematic searches on PubMed, Scopus, and Web of Science Core Collection on 15 January 2026. The search was limited to peer-reviewed original articles published or accepted between 1 January 2020 and 31 December 2025 (inclusive). No language restrictions were applied during the search, but non-English articles were later excluded at the full-text stage (see exclusion criteria). The following search string was used for PubMed (adapted for Scopus and Web of Science with appropriate field tags): (infogest[Title/Abstract] OR “INFOGEST 2.0”[Title/Abstract] OR “INFOGEST protocol”[Title/Abstract]) AND (digestion[Title/Abstract] OR “in vitro digestion”[Title/Abstract] OR digestibility[Title/Abstract] OR bioaccessibility[Title/Abstract]) AND (dairy[Title/Abstract] OR milk[Title/Abstract] OR cheese[Title/Abstract] OR yoghurt[Title/Abstract] OR yogurt[Title/Abstract] OR whey[Title/Abstract] OR casein[Title/Abstract] OR “fermented milk”[Title/Abstract]). For Scopus, the same terms were applied using the TITLE-ABS-KEY field codes. For Web of Science, TS = (topic search) was used. After retrieval, all records were exported to the MySLR platform. Duplicates were identified and removed using an exact match algorithm based on the following fields: title, authors (surname + initials), journal, volume, issue, page range, DOI, and publication year. Records were considered duplicates if all these fields matched exactly. In cases of partial mismatch (e.g., different DOI but identical title and authorship), manual verification was performed by two independent reviewers (G.D.S. and D.M.A-G.). For this systematic review, dairy products are operationally defined as foods derived exclusively from the milk of lactating animals. This includes, but is not limited to, bovine (cow), goat, sheep, buffalo, mare, and camel. The following forms are included: liquid milk (raw, pasteurised, UHT, skimmed, whole, powdered), fermented milks (yoghurt, sour cream, kefir, cultured buttermilk), cheeses (fresh, soft, hard, processed, mould-ripened), whey and whey derivatives (sweet whey, acid whey, whey protein isolate/concentrate), cream, butter, ghee, and infant formula based on animal milk. This definition explicitly excludes plant-based milk alternatives and dairy–plant hybrid products. Inclusion criteria were defined as follows: (i) original research articles applying the INFOGEST protocol; (ii) studies in which the food matrix tested was a milk or dairy product (including bovine, goat, sheep, buffalo, mare, as well as derived products such as cheese, yoghurt, whey, cream, fermented milks, or dairy-based emulsions/gels); (iii) articles reporting sufficient information on the type of milk/dairy matrix and the analytical techniques used post-digestion; (iv) full-text articles written in English. Exclusion criteria were: (i) reviews, meta-analyses, letters, conference papers, comments, book chapters; (ii) studies not including certain updates from the 2019 version; (iii) studies not involving any dairy product (e.g., plant-based milks without presence to dairy, or non-dairy protein sources); (iv) studies that did not perform actual in vitro digestion (e.g., only enzyme assays or theoretical simulations); (v) articles where the full text was not available in English; (vi) duplicate publications from the same dataset. Plant-based milk alternatives were excluded unless used as comparators to dairy milk. This avoids confounding factors (different protein structures, antinutritional factors, dietary fibre) that are not representative of animal-derived dairy matrices and would hinder direct comparison across studies. Disagreements were resolved through discussion to reach a consensus and, in some cases, by means of a third reviewer (P.P.). Data from all included articles were extracted by two authors (G.D.S. and D.M.A-G.) and checked by two authors (E.C. and P.T.). The following information was recorded: authors’ names, publication year, study country, type of milk, thematic area, and methodology used post-INFOGEST, as well as results. 3. Results 3.1. Qualitative Analysis of INFOGEST Usage on Dairy Products A total of 429 records were identified from the initial literature search of the three databases (PubMed, Scopus, and Web of Science), of which 231 were duplicates. Of these, the MySLR tool removed 12 papers because they were reviews. Of the 186 studies remaining, 72 were discarded based on their abstracts. After full-text reading and analysis, 64 records were further excluded for failing to meet the inclusion/exclusion criteria. Therefore, a total of 50 studies were considered eligible. The PRISMA flowchart in Figure 2 shows the selection of the studies for this systematic review. Overall, 50 studies published between 2020 and 2025 were included in the systematic review (Table 1). The selected literature primarily falls within the domains of Food Science and Nutrition, with additional contributions from Biochemistry, Microbiology, Biological, Food Engineering, and Agricultural Sciences, among others. Geographically, the studies were predominantly conducted in Europe, with a majority of contributions from France, Italy, Portugal, Spain, Denmark, and Switzerland, followed by Brazil, China, Greece, Ireland, the UK, and the USA, indicating a strong European research focus alongside a growing global interest. From a methodological perspective, the included studies displayed a high degree of analytical heterogeneity, with a clear predominance of chromatographic and mass spectrometry-based techniques. In particular, LC-MS/MS, UHPLC-HRMS/Q-Orbitrap, GC-MS, and GC-FID were the most frequently employed platforms for molecular characterisation of proteins, peptides, lipids, fatty acids, metabolites, and micronutrients. Protein separation techniques, especially SDS-PAGE, often combined with mass spectrometry approaches (e.g., MALDI-TOF/TOF, ESI-MS), were widely used in studies focused on protein and peptide profiling. Several investigations integrated compositional analyses with biochemical and functional assays, including antioxidant capacity tests, total phenolic and flavonoid content determination, and semi-automated gastrointestinal digestion models (e.g., pH-stat-based approaches). Notably, a substantial proportion of studies published from 2022 onwards incorporated in vitro cellular models, frequently combined with gene expression analyses (qPCR), cell viability assays, inflammatory markers, and oxidative stress measurements. In parallel, multiple studies focused on mineral and trace element characterisation, employing FAAS, ICP-OES, and ICP-MS, often supported by multivariate statistical analyses such as principal component analysis (PCA). Additionally, a subset of studies adopted advanced structural, colloidal, and physicochemical characterisation techniques, including NMR, FTIR-ATR, CLSM, AFM, NTA, tensiometry, rheology, and particle-size/zeta-potential measurements, to investigate food matrix organisation and digestion-related transformations. Bovine milk—in whole, skimmed, pasteurised, UHT, organic, or genotype-specific forms (e.g., A1/A2 β-casein)—was the primary food matrix in the majority of studies, reflecting its central role as a reference model in dairy and nutrition research (Table 1). Several studies focused on isolated bovine milk components, including whey protein isolate (WPI), whey protein concentrate (WPC), lactoferrin, and milk fat globules, as well as engineered dairy-like systems (e.g., protein-stabilised emulsions, polysaccharide-structured gels, and nano-carrier formulations). A substantial proportion of studies investigated fermented dairy products, including yoghurt, fermented milks, sour cream, skyr, cream cheese, gouda-type cheese, cheddar, minas frescal, and fresh cheeses, often differing in fat content, protein composition, starter cultures, or fermentation technology. The food matrices investigated across the included studies are summarised in Table 1. Beyond bovine milk, non-cow dairy sources are also represented. These included goat, sheep, buffalo, mare, and human milk, either as whole matrices or as derived products (e.g., whey, extracellular vesicles, or milk fractions). Goat and sheep milk were particularly frequent in comparative studies, while buffalo milk and mare milk were examined in more targeted investigations addressing unique compositional or functional traits. Human milk and infant formula were included in a limited number of studies, mainly for comparative or translational purposes. Several studies focused specifically on whey and whey-derived products, including sweet whey from cheese production, acid whey, protein isolates, and whey-based delivery systems, underscoring the relevance of whey as both a by-product and a functional ingredient. Additionally, a smaller subset of studies examined complex or reformulated dairy systems, such as fortified yoghurts, lipid-enriched products, nanoemulsions, and bioactive-compound-enriched products (e.g., ω-3 fatty acids, α-tocopherol, milk fat globule membrane). Table 2 summarises the macronutrients investigated using the INFOGEST 2.0 simulated gastrointestinal digestion protocol and the primary outcomes assessed across the included studies. Proteins were the most frequently studied macronutrient, either as whole milk proteins, purified fractions (e.g., κ-casein, lactoferrin), whey protein isolates, or protein hydrolysates. Across studies, protein-related outcomes predominantly included digestibility, bioaccessibility, and peptide release following digestion. Digestibility was commonly assessed through degree of hydrolysis, proteolysis kinetics, and release of free amino acids, whereas peptide release studies focused on identifying digestion-derived peptides, including low-molecular-weight and digestion-resistant fractions. Several investigations extended these analyses to functional or biological endpoints, such as effects on glucose homeostasis markers or immunomodulatory activity of bioactive peptides generated during digestion. A smaller but consistent subset of studies addressed lipid digestion, focusing on lipid digestibility, free-fatty-acid (FFA) release kinetics, and bioaccessibility of lipid classes, including phospholipids and short- and medium-chain triglycerides. These studies often applied pH-stat approaches and kinetic modelling to characterise lipolysis under simulated gastrointestinal conditions. More recent works integrated lipid digestion outcomes with structural and physicochemical parameters of the food matrix, highlighting the influence of matrix organisation on lipid bioaccessibility. Carbohydrates were less frequently investigated and were primarily represented by studies on exopolysaccharides (EPSs) and prebiotic components. These works focused on EPS quantification during fermentation, stability under digestive conditions, and their relationship with functional properties, such as postbiotic activity or sensitivity to pH and temperature. Several studies adopted a multi-macronutrient approach, simultaneously evaluating proteins, lipids, and/or carbohydrates within the same food matrix. These integrated designs enabled comparative assessment of digestion behaviour and bioaccessibility across macronutrient classes and supported a more holistic understanding of food matrix disassembly during digestion. Overall, the evidence base of micronutrient post-digestion studies in animal dairy products is dominated by mineral bioaccessibility, with a smaller but growing number of investigations addressing fat-soluble vitamins, carotenoids, bioactive lipids, and other non-classical micronutrients (Table 3). Minerals represent the most frequently studied micronutrient class. Calcium was the most extensively investigated element, either alone or in combination with other minerals (e.g., magnesium, phosphorus, potassium, zinc), with outcomes primarily focused on bioaccessibility, or solubility following digestion. Several studies extended mineral analysis to multi-element panels, including both essential trace elements (e.g., iron, zinc, selenium, copper, manganese) and non-essential or potentially toxic elements, evaluated mainly in terms of bioaccessibility. Comparative designs assessing different food matrices, including dairy versus plant-based systems, were also reported. A second group of studies focused on fat-soluble micronutrients, including vitamin K, α-tocopherol (vitamin E), and provitamin A carotenoids (β-carotene). These investigations primarily assessed bioaccessibility, stability, and recovery after in vitro digestion, often highlighting the influence of food matrix composition, lipid content, and processing conditions (e.g., encapsulation, pH, temperature) on micronutrient release and retention. Several studies addressed bioactive lipids, particularly ω-3 fatty acids, evaluating their bioaccessibility, digestion kinetics, and contribution to antioxidant capacity within complex dairy matrices. These works often integrated kinetic lipolysis data with bioaccessibility endpoints, providing insight into the digestion behaviour of lipid-soluble micronutrients. Finally, more recent investigations expanded the scope of INFOGEST applications to include non-traditional micronutrients and bioactive compounds, such as phenolics, flavonoids, conserved microRNAs, and milk extracellular vesicles (EVs). These studies primarily focused on stability, integrity, recovery, and matrix-dependent retention during digestion, reflecting an emerging interest in the fate of regulatory and functional food components beyond classical vitamins and minerals. 3.2. Demonstrated Biological Activities of Dairy Digesta in In Vitro Systems Only eight studies among the selected studies complement the standardised INFOGEST digestion protocol with intestinal or intestinal-related cell models (Table 4 and Figure 3). Most studies employed Caco-2 monolayers or Caco-2/HT-29 co-cultures, while selected investigations extended the analysis to NCM460 healthy intestinal epithelial cells or extra-intestinal models (e.g., Saos-2 osteoblast-like cells). The food matrices investigated included casein and whey proteins, fermented milks, acid whey from yoghurt, caseinophosphopeptides, osteopontin, and whey-based beverages. However, the focus was on bioactive peptides. 3.2.1. Antioxidant Activity and Oxidative Stress Modulation Several studies consistently reported that digestion enhanced or preserved the antioxidant activity of dairy-derived matrices. Digestion-resistant whey peptides significantly reduced intracellular ROS levels in Caco-2 cells exposed to oxidative stress, while preventing glutathione depletion and excessive antioxidant enzyme activation [40]. Similarly, fermented milks enriched with exopolysaccharide-producing Lactiplantibacillus plantarum strains showed improved antioxidant capacity after digestion and attenuated ROS production in NCM460 cells under both oxidative and inflammatory conditions [71]. Casein-derived peptides and caseinophosphopeptides generated after INFOGEST digestion displayed dose-dependent antioxidant effects, comparable to or exceeding vitamin C in Caco-2/HT-29 co-cultures and retained activity after intestinal metabolism [21]. Whey-based beverages also showed increased antioxidant bioaccessibility post-digestion, with bioaccessible fractions significantly lowering ROS generation in Caco-2 cells [30]. 3.2.2. Transepithelial Transport and Barrier Integrity Multiple studies evaluated intestinal transport and epithelial integrity following digestion. Whey peptides and milk-derived protein fragments exhibited measurable transepithelial transport across Caco-2 monolayers, with permeability influenced by peptide size, terminal residues, and resistance to brush-border peptidases [32]. TEER measurements confirmed preservation or recovery of barrier integrity following exposure to selected digested dairy matrices. 3.2.3. Mineral Bioaccessibility and Cellular Uptake Calcium bioavailability was specifically addressed in yoghurt acid whey and dairy matrices. Following INFOGEST digestion, calcium bioaccessibility was significantly higher in yoghurt acid whey compared with milk, although no differences were observed in calcium transport across Caco-2 cells or in the expression of calcium transport-related genes (TRPV6, VDR, S100G, PMCA1) [63]. Comparable results were reported for cheeses, where mineral bioaccessibility depended on matrix composition and processing, while cellular transport efficiency did not strictly mirror soluble mineral fractions, highlighting the importance of the food matrix rather than total mineral content alone [29]. 3.2.4. Immunomodulatory and Metabolic Readouts Beyond antioxidant and barrier-related endpoints, digested whey fractions modulated inflammatory and metabolic pathways. Sweet whey-derived peptides altered the expression of inflammation-related genes in THP-1 macrophages, with effects depending on milk origin and inflammatory status [61]. In enteroendocrine models, digested matrix enhanced GLP-1 secretion, upregulated GCG and PCSK1, and inhibited DPP-IV activity after intestinal barrier passage, indicating preserved metabolic bioactivity after digestion [44]. 4. Discussion The INFOGEST protocol has emerged as a pivotal technique for studying in vitro gastrointestinal digestion, providing a standardised methodology for evaluating the digestibility and bioavailability of nutrients across diverse food matrices. This review highlights its application to milk and dairy products. Notably, the methodology’s impact has seen a significant rise since 2019, following the publication of the INFOGEST 2.0 protocol by Brodkorb and collaborators [3], which has driven widespread adoption and expanded its relevance in food and nutritional sciences. Several factors may culminate in the consideration of dairy products as food matrices of choice in the INFOGEST application. This includes, among others, the use of milk as the reference validation matrix by inter-laboratory trials of the initial INFOGEST procedure [15] and the demonstrated physiological relevance for milk digestion specifically, i.e., correspondence to in vivo outcomes [73]. Similarly, we observed a significant application of the digestion model to the food group in question in Europe and Latin America (mainly Brazil). This may be driven by the consistent use of dairy as food in these regions [74]. While a number of developing countries produce and consume considerable quantities of dairy products, especially buffalo milk [75,76], the INFOGEST application on such food matrices is very limited. A clear convergence in analytical approaches was observed across studies, with recurring use of chromatographic, mass spectrometric, spectrophotometric, and imaging techniques. This consistency suggests the emergence of an implicit analytical framework accompanying standardised in vitro digestion models. High-resolution mass spectrometry platforms are predominantly employed to characterise the molecular composition of digesta, while chromatographic techniques facilitate fractionation and targeted analysis [77]. In parallel, spectrophotometric and electrophoretic methods remain essential for quantifying digestion kinetics and validating the extent of proteolysis. Targeted assays, such as ELISA and qPCR, further enable the tracking of specific biomolecules, reflecting increasing interest in the stability and bioactivity of functional components. Additionally, imaging approaches provide insight into microstructural transformations that influence digestive behaviour. Collectively, these techniques constitute a multi-scale analytical strategy spanning molecular, structural, and functional levels. This consistency in analytical approaches across studies suggests an implicit standardisation not only of digestion protocols but also of downstream characterisation, enabling comparability and reproducibility across the field. 4.1. Bovine: The Matrix of Interest Bovine milk and its products, as the current trend suggests, remain the food matrix of interest, while other members of the dairy food group are barely studied. This includes buffalo milk, which accounts for 15% of the global dairy usage, being the second-highest contributor [78]. This food matrix bias reflects broader trends in dairy research, where cow-derived systems remain the default experimental model. Also, there is consideration for industrial relevance and compatibility as the primary validation matrix [14]. The extensive compositional characterisation and methodological familiarity associated with bovine systems likely contribute to their preferential selection, reinforcing a cycle of continued focus. However, this dominance limits the broader applicability and direct extrapolation of findings derived predominantly from bovine systems, as alternative dairy matrices, including buffalo and sheep milk, exhibit distinct physicochemical properties that influence digestion behaviour and nutrient bioaccessibility [79]. Also, while casein is the most studied component of the products in terms of hydrolysis and digestibility, whey proteins often find applications in studies examining modified food structural behaviour under digestion. 4.2. Dairy Protein Digestion Output While a broadly conserved peptide fingerprint emerges at the end of digestion, this convergence reflects both a strength and a limitation of the approach. On the one hand, the digestive model has enabled systematic comparisons of digestibility and peptide release at the level of protein fractions and variants. The reproducibility of intestinal peptide profiles across static and dynamic systems and with reported correlations to in vivo data of up to 0.8 [27] supports the model’s robustness in capturing general proteolytic outcomes. Casein-derived peptides, particularly from κ- and β-casein, consistently dominate investigations [30,32,34,38,47], resulting in large repertoires (as high as 500) of peptides from resistant proteins such as caseinophosphopeptides [21,54]. On the other hand, this apparent uniformity may obscure physiologically relevant nuances. Variations introduced by calcium content (for instance, low calcium content consistently yields high peptide variety), casein structuring, or microbial diversity in fermented products demonstrate that upstream factors can significantly reshape peptide composition [21,22], yet these differences are not always fully resolved within standard INFOGEST conditions. Efforts to incorporate brush border enzymes or adapt the protocol to specific populations (e.g., elderly or preterm models) represent important advances [32], revealing extended cleavage patterns and distinct peptide pools. Parallel progress has been made in understanding how protein structure and food matrix design influence digestion kinetics, an area where INFOGEST has proven particularly informative. Studies show that modifying protein architecture, through hydrolysis, gelation, high-pressure processing, or encapsulation, can significantly alter enzyme accessibility and shift the site and extent of proteolysis as well as the release of other dairy food components [25,34,38,44,72]. For example, whey protein hydrolysates are consistently more digestible than isolates, while gel microstructure and surface area dictate gastric breakdown rates [44,72]. Encapsulation and conjugation strategies further demonstrate controlled digestion, often delaying hydrolysis until the intestinal phase [48,56]. In spite of these modifications, the role of phenotypic and genotypic differences on dairy protein origin, particularly casein variants, does not go unnoticed [34,38,47]. These findings relate the model’s sensitivity to structural modifications and natural variability as well as its utility in designing functional foods. Overall digestibility values are typically high (80–99%), aligning well with in vivo data and reinforcing confidence in quantitative outputs such as DIAAR estimates [45,80], and this stands as perhaps the most progressive application of the model. This may have potential applications in food composition research and industry, enabling estimation of food protein quality without the need for in vivo models. However, the model is less discriminative in linking these differences to downstream physiological effects. While numerous bioactive peptides are identified in dairy protein digesta—exhibiting antioxidant, antihypertensive, metabolic (e.g., GLP-1 stimulation, DPP-IV inhibition), and barrier-protective functions (Figure 3)—the translation of these findings remains constrained by the model’s lack of unified absorption, metabolism, and systemic feedback models that can directly fuse the demonstrated activity to a specific peptide in the dairy product digesta [21,30,40,44,61,81]. Additionally, dose-dependent or context-specific effects (including potential pro-inflammatory responses) are difficult to interpret within a purely digestive framework. Thus, while INFOGEST has significantly advanced the characterisation of dairy protein digestion and peptide bioactivity, its application, going forward, will benefit from sound experimentation that can complement models to fully resolve the functional relevance of the peptides it so effectively generates. 4.3. Dairy Lipid Digestive Behaviour With the increasing availability of pH-stat instrumentation, its accessories, and its accompanying simplicity, which present an attractive avenue for studying lipase activity and lipolysis [82], the use of the in vitro digestion model to understand lipid digestion in dairy systems reflects a growing capacity to capture trends in fat bioaccessibility. A consistent observation is that dynamic and semi-dynamic models yield higher and more physiologically nuanced estimates of lipolysis and fatty acid release than static protocols, particularly for milk fat. For example, dynamic conditions enhance overall bioaccessibility, while also revealing preferential release of medium-chain fatty acids (C8:0–C12:0) over longer-chain species [23,26] and shifting lipid profiles toward increased relative proportions of MUFAs and PUFAs, with concomitant reductions in SFAs [30]. However, these outputs are strongly modulated by the surrounding food matrix: increasing matrix complexity can either enhance lipolysis (e.g., through protein-mediated stabilisation of fat globules) [36] or suppress it (e.g., via polyphenol-rich components such as tea or grape seed) [23,37], highlighting that the model is sensitive to compositional context but not always predictive across substrates. Hence, advances in structural and processing considerations have demonstrated the protocol’s utility. Homogenization, for instance, improves lipid digestibility and phospholipid retention [35]. Hence, the digestive model can detect microstructural effects on enzyme accessibility. Age-related adaptations (e.g., elderly models) equally suggest reductions in lipolysis in the presence of digestive-resistant protein or low gastric lipase, raising concerns of inefficient dairy fat digestion in children or infants with low human gastric lipase production, such as non-Helicobacter pylori gastritis [57,83]. At a broader level, the model has been applied to help profile post-digestion dairy lipids, providing a clearer understanding of the in vivo trend. This progress has benefited greatly from the semi-dynamic adaptations, allowing more thermal and pH control during the digestion process, although such outputs still require cautious interpretation, particularly based on the specific digestive conditions employed, since the INFOGEST recommendations are sometimes not strictly applied. 4.4. Micronutrient Bioaccessibility and Bioactive Components Application of the model to calcium and other micronutrients in dairy systems demonstrates both its utility in estimating bioaccessibility and its limitations in predicting true bioavailability. Calcium bioaccessibility across dairy matrices is generally moderate but very variable (ranging from 11 to 75%) [29,43,49,51,63,70], often exceeding that of plant-based alternatives [43,70]. While the bioaccessibility of many minerals falls within this range, others might have a higher level than calcium within the same food matrix [43,51]. Also, variability in bioaccessibility may be dependent on dairy fraction or the nature of production (e.g., yoghurt acid whey vs. milk, or organic vs. conventional milk), although not usually on dairy origin [51,63]. Casein digestion plays a central mechanistic role, with the release of large numbers of caseinophosphopeptides likely contributing to mineral solubilisation and stabilisation during digestion, suggesting a higher potential of absorption in caseinophosphopeptide-rich dairy products such as cheese [21,29,84,85]. Despite these variations, cellular uptake may be comparable [50,63]. Fat-soluble vitamins also show substantial but more variable bioaccessibility [25,28,86]. Structural strategies, such as protein-based emulsions or coacervates, improve the stability and delivery of encapsulated micronutrients, indicating the model’s sensitivity to modified food structure design. Dairy bioactives show clear matrix- and component-dependent digestive stability and functionality under INFOGEST application. Probiotic survival is generally enhanced by structured or solid matrices (e.g., bigels, cheese) compared to liquid systems [24,32], although responses remain strain-specific, and many lactic acid bacteria display intrinsic tolerance to digestion [33]. Functional activity can also be retained, as probiotic-fortified digesta exhibit anti-inflammatory effects in intestinal models. In contrast, extracellular vesicles show partial sensitivity, with reduced marker intensity and particle numbers despite relative preservation of structure and miRNA cargo [55,59]. For other bioactives, such as phenolics, dairy matrices can improve bioaccessibility (up to ~130%) but reduce compound diversity [87]. Overall, the in vitro digestion model effectively captures trends in bioactive protection and release but remains limited in resolving their full structural integrity and physiological relevance. 4.5. Concerns: Applications and Downstream Models The use of the in vitro digestion model, despite the publication of the harmonised recommendation, continues to be coupled with substantial alterations. The area of dairy food is not left out. Such modifications include a lower enzyme-to-food ratio, a higher food/simulated fluid ratio, inconsistent use of gastric lipase, and incubation times longer than the recommended figures [34,38,55,72]. Similarly, there is a growing adaptation of the static digestive model to integrate properties of a dynamic one. The increased availability of instrumentation (e.g., pH-stats, pumps, and jacketed vessels), which can permit the modulation of the biophysical aspects of the digestive model, including pH and temperature, may promote a more prominent widespread adoption of this mode of in vitro digestion. Such measures have been employed and have aided in demystifying the digestion of the lipid component of dairy matrices and associated components (e.g., beta-carotene) [26,54,56]. Similarly, despite the increasing adoption of cell-based approaches alongside the INFOGEST protocol, their implementation remains limited (~20% of the studies). The majority of bioactive functional studies are limited to peptides, while other components (lipids, extracellular vesicles and their cargoes, probiotics) are rarely ventured into. Particularly, the predominance of Caco-2-based models highlights a methodological bottleneck in current INFOGEST applications, where advances in digestion simulation are not matched by equally sophisticated biological validation systems. This overreliance constrains the physiological relevance of post-digestion assessments, as it fails to capture the multicellular, immune, and microbiota-driven processes that influence nutrient bioavailability and bioactivity in vivo. There are also cases of overextension of bioaccessibility into bioavailability when cell absorption assays were employed. All the same, this integrative approach has significantly expanded the functional interpretation of in vitro digestion outcomes. For instance, Tenenbaum et al. [44] work showed a methodological prowess in this regard by combining Caco 2 cells with mucus-secreting and enteroendocrine cells, which allows for a structural and functional setup of the intestine. A few others employed co-cultured cell lines [21] and considered brush border membrane peptidases to aid near-in vivo hydrolysis of peptides in a way that did not influence the digest’s peptide profile [32]. Hence, there is a significant attempt in the evaluation of dairy nutrients’ bioaccessibility via this route. However, care should be taken not to overrepresent the translational relevance of the current post-digestion biological validation systems to the in vivo context. For instance, nutrient permeability in a model lacking physiological diversity [29,32] or the biological activity of the digests on an isolated model [21,40] may not accurately present such functional relevance of digestion products, especially on a system-wide level. Consequently, the heterogeneity observed across studies made it methodologically inappropriate to perform a meta-analysis. Even though the standardised digestion protocol (INFOGEST 2.0) was used. 5. Future Research Directions While INFOGEST-based digestomics is a relatively recent field, the methodological quality of the retrieved studies was robust enough to allow for a detailed systematic analysis and the formulation of evidence-based conclusions. Nevertheless, as the field of food and nutrition science evolves, several avenues open up for expanding the protocol’s application and impact on the milk industrial process [88]. For instance, downstream analysis of the digestion products is mainly focused on compositional and structural examinations. Similarly, a fraction of the literature that endeavoured functional studies employed narrow post-digestion biological systems. Hence, this limits the understanding of the biological activity of bioactive components of dairy products post-digestion [88,89]. To this end, considerations should be given to the use of more dynamic, physiological diverse, and encompassing models such as organoids and microfluidic complex models (e.g., intestine-on-chips) which replicates, more physiologically, the in vivo intestinal wall through the facilitation of cell–cell interactions and the provision of crucial biophysical cues such as perfusion and mechanical actuation and other factors that are vital to the investigation of intestinal epithelial integrity [90,91,92]. Such systems may be extended to include the gut microbiota in a way that permits monitoring microbiome-related changes in the digesta [93,94]. This will change the landscape of study outcome from bioaccessibility (which the current trend mainly depicts) to a more reliable “pseudo-bioavailability”. Despite the widespread consumption of buffalo milk in developing regions, its investigation using the INFOGEST protocol remains limited, and this only gives an indication of the predominant use of bovine matrix. This discrepancy likely arises from the technical and economic demands associated with standardised digestion models and advanced analytical techniques. However, several cost-effective approaches, including tiered implementation of the digestion protocol (for example, stratifying the protocol into low-cost core digestion and sophisticated advanced-level models), the use of spectrophotometric and electrophoretic proxies for digestion assessment (low-cost analytics), and collaborative analytical frameworks, could facilitate broader adoption. This will ensure that standardised in vitro digestion models are applied to nutritionally and regionally relevant food matrices, in a manner that not only improves the global applicability of digestion research but also aid regional-relevant policy making. Also, expanding its application to non-conventional dairy matrices and fortified products would also support the development of functional foods, as the current trend indicates an uneven, concentrated effort on bovine and caprine products. Additionally, while significant strides have been made in the examination of dairy lipids’ post-digestive attributes, there is a dearth of inquiries into their functional or biological properties. Hence, replicating functional investigations, at least as seen in the case of dairy proteins, will benefit the fields of food science, nutrition, and health at large. Furthermore, while adaptations of the protocol into semi-dynamic ones, which could provide more comprehensive insights into the temporal aspects of digestion and nutrient release, begin to ensue, there may be an impending problem of “reverse standardisation” of the protocol, where the already-unified protocol becomes a source of varying, instrument-driven, uncoordinated, and therefore, non-replicable models. Hence, a unified recommendation for the semi-dynamic adaptation of the INFOGEST 2.0 model is needed. Such an approach should retain a standardised static core while allowing for the controlled modification of key physiological parameters, including pH progression, enzyme delivery, and gastric emptying. The adoption of predefined dynamic modules, combined with a minimum reporting checklist, would enhance reproducibility and enable meaningful cross-study comparisons while accommodating varying levels of technical capability (Figure 4). 6. Conclusions The INFOGEST protocol has established itself as a robust and internationally harmonised framework for the in vitro investigation of gastrointestinal digestion, with its application to milk and dairy products proving particularly fruitful. This review demonstrates that, since the publication of INFOGEST 2.0, there has been a marked acceleration in the use of the protocol across diverse dairy matrices to interrogate the digestibility of macronutrients, the bioaccessibility of micronutrients, and the generation of bioactive peptides with antioxidant, anti-inflammatory, and antihypertensive potential. The integration of advanced analytical platforms, alongside intestinal epithelial cell models, has substantially laid a meaningful foundation for the mechanistic and functional interpretation of dairy protein and lipid digestion. However, its application remains marked by growing methodological divergence, particularly through protocol modifications and semi-dynamic adaptations that risk undermining reproducibility. Concomitantly, the limited integration of advanced biological validation systems constrains the translation of digestion outcomes into meaningful physiological relevance. Future progress will depend on balancing standardisation with controlled flexibility, through harmonised dynamic extensions, and expanding downstream models toward more physiologically representative systems. Broadening accessibility and application to diverse dairy matrices will also be essential to ensure global relevance. Collectively, these efforts will shift the field from descriptive bioaccessibility toward a more integrated and predictive understanding of nutrient bioavailability.